Compliance by Design: Governing AI ‐Augmented Quantitative Analysis in Clinical and Translational Research
Open Access
- 29 October 2026
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (11) , e70747
Abstract
Artificial intelligence (AI) is moving from promise to routine practice in clinical and translational research, and large language models (LLMs) are now used to scope analyses, draft and debug code, and accelerate the quantitative work that supports clinical and translational decisions. This adoption is outpacing the operational safeguards that keep such work reproducible and auditable, and the central risk is not only erroneous code but the quieter erosion of the analytical discipline on which trustworthy bench‐to‐bedside decisions depend. In this position paper, we argue that AI can be integrated into regulated quantitative workflows without sacrificing reproducibility, provided it operates inside a compliance‐by‐design architecture built on two principles: analytical intent must be formally encoded and locked before execution, and the analysis itself must run outside the LLM as specification‐verified code in a validated environment. We describe three failure modes that ordinary quality control does not detect, namely context drift, the displacement effect, and implementation drift, and we link each to documented model behavior. For open‐ended investigation, these principles are operationalized as a four‐step execution firewall; for recurring development studies such as assay validations and animal safety studies, they are operationalized through a governed library of documented, validated agents, supported by fit‐for‐purpose validation, a clear separation of human and machine roles, and post‐deployment monitoring. Both approaches can be implemented with components available today. Used this way, AI enhances rather than replaces quantitative expertise, which now resides less in the code a model produces than in the constraints a scientist defines before it runs.Keywords
This publication has 13 references indexed in Scilit:
- How AI Transforms Regulatory Submission: Current Clinical Implementation and Future ProspectsClinical and Translational Science, 2025
- Artificial Intelligence in Clinical and Translational Science : From Bench Insights to Bedside ImpactClinical and Translational Science, 2025
- AI ‐ NLME : A New Artificial Intelligence‐Driven Nonlinear Mixed Effect Modeling Approach for Analyzing Longitudinal Data in Randomized Placebo‐Controlled Clinical TrialsClinical and Translational Science, 2025
- AI‐Driven Applications in Clinical Pharmacology and Translational Science: Insights From the ASCPT 2024 AI PreconferenceClinical and Translational Science, 2025
- Large Language Models and Their Applications in Drug Discovery and Development: A PrimerClinical and Translational Science, 2025
- Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational SciencesClinical and Translational Science, 2025
- AI In Action: Redefining Drug Discovery and DevelopmentClinical and Translational Science, 2025
- An Empirical Study of the Non-Determinism of ChatGPT in Code GenerationACM Transactions on Software Engineering and Methodology, 2025
- Lost in the Middle: How Language Models Use Long ContextsTransactions of the Association for Computational Linguistics, 2024
- Survey of Hallucination in Natural Language GenerationACM Computing Surveys, 2023